164 related articles for article (PubMed ID: 27913161)
1. Novel brain expressed RNA identified at the MIR137 schizophrenia-associated locus.
Gianfrancesco O; Warburton A; Collier DA; Bubb VJ; Quinn JP
Schizophr Res; 2017 Jun; 184():109-115. PubMed ID: 27913161
[TBL] [Abstract][Full Text] [Related]
2. Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus.
Gianfrancesco O; Griffiths D; Myers P; Collier DA; Bubb VJ; Quinn JP
J Mol Neurosci; 2016 Oct; 60(2):239-47. PubMed ID: 27525637
[TBL] [Abstract][Full Text] [Related]
3. A rare functional noncoding variant at the GWAS-implicated MIR137/MIR2682 locus might confer risk to schizophrenia and bipolar disorder.
Duan J; Shi J; Fiorentino A; Leites C; Chen X; Moy W; Chen J; Alexandrov BS; Usheva A; He D; Freda J; O'Brien NL; ; ; McQuillin A; Sanders AR; Gershon ES; DeLisi LE; Bishop AR; Gurling HM; Pato MT; Levinson DF; Kendler KS; Pato CN; Gejman PV
Am J Hum Genet; 2014 Dec; 95(6):744-53. PubMed ID: 25434007
[TBL] [Abstract][Full Text] [Related]
4. Chromosome 1p21.3 microdeletions comprising DPYD and MIR137 are associated with intellectual disability.
Willemsen MH; Vallès A; Kirkels LA; Mastebroek M; Olde Loohuis N; Kos A; Wissink-Lindhout WM; de Brouwer AP; Nillesen WM; Pfundt R; Holder-Espinasse M; Vallée L; Andrieux J; Coppens-Hofman MC; Rensen H; Hamel BC; van Bokhoven H; Aschrafi A; Kleefstra T
J Med Genet; 2011 Dec; 48(12):810-8. PubMed ID: 22003227
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells.
Hill MJ; Donocik JG; Nuamah RA; Mein CA; Sainz-Fuertes R; Bray NJ
Schizophr Res; 2014 Mar; 153(1-3):225-30. PubMed ID: 24556472
[TBL] [Abstract][Full Text] [Related]
6. A GWAS SNP for Schizophrenia Is Linked to the Internal MIR137 Promoter and Supports Differential Allele-Specific Expression.
Warburton A; Breen G; Bubb VJ; Quinn JP
Schizophr Bull; 2016 Jul; 42(4):1003-8. PubMed ID: 26429811
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a REST-Regulated Internal Promoter in the Schizophrenia Genome-Wide Associated Gene MIR137.
Warburton A; Breen G; Rujescu D; Bubb VJ; Quinn JP
Schizophr Bull; 2015 May; 41(3):698-707. PubMed ID: 25154622
[TBL] [Abstract][Full Text] [Related]
8.
Liu S; Li A; Liu Y; Li J; Wang M; Sun Y; Qin W; Yu C; Jiang T; Liu B
Psychol Med; 2020 Jul; 50(9):1510-1518. PubMed ID: 31239006
[TBL] [Abstract][Full Text] [Related]
9. Experimental validation of candidate schizophrenia gene CALN1 as a target for microRNA-137.
Xia S; Zhou X; Wang T; Zhang Q; Li Q; Liu Y; Xing Q; Wang L; He L; Zhao X
Neurosci Lett; 2015 Aug; 602():110-4. PubMed ID: 26163462
[TBL] [Abstract][Full Text] [Related]
10. Loci with genome-wide associations with schizophrenia in the Han Chinese population.
Li Z; Xiang Y; Chen J; Li Q; Shen J; Liu Y; Li W; Xing Q; Wang Q; Wang L; Feng G; He L; Zhao X; Shi Y
Br J Psychiatry; 2015 Dec; 207(6):490-4. PubMed ID: 26206863
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide association study identifies five new schizophrenia loci.
Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium
Nat Genet; 2011 Sep; 43(10):969-76. PubMed ID: 21926974
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.
Sakamoto K; Crowley JJ
Am J Med Genet B Neuropsychiatr Genet; 2018 Mar; 177(2):242-256. PubMed ID: 29442441
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide schizophrenia variant at MIR137 does not impact white matter microstructure in healthy participants.
Kelly S; Morris DW; Mothersill O; Rose EJ; Fahey C; O'Brien C; O'Hanlon E; Gill M; Corvin AP; Donohoe G
Neurosci Lett; 2014 Jun; 574():6-10. PubMed ID: 24820543
[TBL] [Abstract][Full Text] [Related]
14. The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
Vogel BO; Lett TA; Erk S; Mohnke S; Wackerhagen C; Brandl EJ; Romanczuk-Seiferth N; Otto K; Schweiger JI; Tost H; Nöthen MM; Rietschel M; Degenhardt F; Witt SH; Meyer-Lindenberg A; Heinz A; Walter H
Schizophr Res; 2018 May; 195():190-196. PubMed ID: 28958479
[TBL] [Abstract][Full Text] [Related]
15. Effects of MiR-137 genetic risk score on brain volume and cortical measures in patients with schizophrenia and controls.
Cosgrove D; Mothersill DO; Whitton L; Harold D; Kelly S; Holleran L; Holland J; Anney R; ; Richards A; Mantripragada K; Owen M; O'Donovan MC; Gill M; Corvin A; Morris DW; Donohoe G
Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):369-376. PubMed ID: 29418072
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional targets of the schizophrenia risk gene MIR137.
Collins AL; Kim Y; Bloom RJ; Kelada SN; Sethupathy P; Sullivan PF
Transl Psychiatry; 2014 Jul; 4(7):e404. PubMed ID: 24984191
[TBL] [Abstract][Full Text] [Related]
17. MIR137 schizophrenia-associated locus controls synaptic function by regulating synaptogenesis, synapse maturation and synaptic transmission.
He E; Lozano MAG; Stringer S; Watanabe K; Sakamoto K; den Oudsten F; Koopmans F; Giamberardino SN; Hammerschlag A; Cornelisse LN; Li KW; van Weering J; Posthuma D; Smit AB; Sullivan PF; Verhage M
Hum Mol Genet; 2018 Jun; 27(11):1879-1891. PubMed ID: 29635364
[TBL] [Abstract][Full Text] [Related]
18. The MIR137 VNTR rs58335419 Is Associated With Cognitive Impairment in Schizophrenia and Altered Cortical Morphology.
Mahmoudi E; Atkins JR; Quidé Y; Reay WR; Cairns HM; Fitzsimmons C; Carr VJ; Green MJ; Cairns MJ
Schizophr Bull; 2021 Mar; 47(2):495-504. PubMed ID: 32910167
[TBL] [Abstract][Full Text] [Related]
19. The impact of MIR137 on dorsolateral prefrontal-hippocampal functional connectivity in healthy subjects.
Liu B; Zhang X; Hou B; Li J; Qiu C; Qin W; Yu C; Jiang T
Neuropsychopharmacology; 2014 Aug; 39(9):2153-60. PubMed ID: 24625753
[TBL] [Abstract][Full Text] [Related]
20. Resequencing and association analysis of MIR137 with schizophrenia in a Japanese population.
Egawa J; Nunokawa A; Shibuya M; Watanabe Y; Kaneko N; Igeta H; Someya T
Psychiatry Clin Neurosci; 2013 May; 67(4):277-9. PubMed ID: 23683160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
